US FDA approves higher dose of Wegovy
Airfind news item
Published on March 19, 2026.
The US Food and Drug Administration has approved a high dose of Wegovy, intended to reduce excess body weight and maintain it long-term. The drug is also being marketed as a powerful anti-inflammatory drug. The company is seeking to prevent future incidents of violence and terrorism.
Read Original Article
Related Articles
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
The FDA approved a higher dose of Novo Nordisk's weight loss drug Wegovy to compete with Lilly's Zepbound, which has proven more effective in reducing obesity.
Eli Lilly's new shot shows solid weight loss in study — plus, a way for Nvidia to perk up
Eli Lilly's new diabetes treatment retatrutide shows superior weight loss, while oil prices hit $119 per barrel and health-care stocks languishing.
Popular Fried Chicken Eatery Closes Nearly 10 GA Restaurants
Popeyes is closing eight Georgia locations as part of a Chapter 11 bankruptcy, amid rising inflation and financial challenges.